Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBIT (2016 - 2025)

Alkermes (ALKS) has disclosed EBIT for 16 consecutive years, with $58.1 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT rose 128.7% to $58.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $254.0 million, a 357.83% increase, with the full-year FY2025 number at $254.0 million, up 357.83% from a year prior.
  • EBIT was $58.1 million for Q4 2025 at Alkermes, down from $89.1 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $239.2 million in Q2 2023 to a low of -$202.5 million in Q4 2024.
  • A 5-year average of $40.9 million and a median of $50.7 million in 2024 define the central range for EBIT.
  • Peak YoY movement for EBIT: plummeted 879.39% in 2022, then skyrocketed 794.18% in 2023.
  • Alkermes' EBIT stood at $129.4 million in 2021, then decreased by 8.98% to $117.8 million in 2022, then dropped by 17.9% to $96.7 million in 2023, then tumbled by 309.37% to -$202.5 million in 2024, then soared by 128.7% to $58.1 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's EBIT are $58.1 million (Q4 2025), $89.1 million (Q3 2025), and $93.0 million (Q2 2025).